| WEA |
WESTERN ASSET PREMIER BOND FUND |
Common Shares of Beneficial Interest |
18% |
$22,945,132 |
+$2,736,635 |
2,106,991 |
+14% |
Morgan Stanley |
31 Mar 2026 |
| KTCC |
KEY TRONIC CORP |
Common Stock |
15% |
$5,621,814 |
-$471,954 |
1,592,582 |
-7.7% |
Morgan Stanley |
30 Sep 2025 |
| OPPPRB |
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. |
4.75% Series B Cumulative Preferred Shares |
14% |
$6,335,258 |
+$1,123,034 |
345,811 |
+22% |
Morgan Stanley |
31 Dec 2025 |
| XOMA |
XOMA Royalty Corp |
Common Stock |
14% |
$46,207,071 |
+$4,805,083 |
1,702,545 |
+12% |
Morgan Stanley |
31 Dec 2025 |
| ABUS |
Arbutus Biopharma Corp |
Common Shares |
14% |
$122,814,997 |
+$20,788,104 |
25,910,337 |
+20% |
Morgan Stanley |
31 Dec 2025 |
| FPF |
First Trust Intermediate Duration Preferred & Income Fund |
Common Stock |
13% |
$151,036,759 |
|
7,887,037 |
|
Morgan Stanley |
30 Sep 2025 |
| BMN |
BlackRock 2037 Municipal Target Term Trust |
Common Shares of Beneficial Interest |
13% |
$19,106,998 |
+$1,719,868 |
799,456 |
+9.9% |
Morgan Stanley |
31 Mar 2025 |
| AGL |
agilon health, inc. |
Common Stock |
12% |
$192,768,956 |
|
50,200,249 |
|
Morgan Stanley |
31 Mar 2025 |
| GBAB |
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust |
Common Shares of Beneficial Interest |
11% |
$45,937,842 |
+$5,347,760 |
3,168,127 |
+13% |
Morgan Stanley |
31 Mar 2026 |
| BLW |
BLACKROCK Ltd DURATION INCOME TRUST |
Common Stock |
11% |
$52,889,852 |
|
4,167,837 |
|
Morgan Stanley |
31 Mar 2026 |
| NSIT |
INSIGHT ENTERPRISES INC |
Common Stock |
10% |
$272,739,654 |
+$24,240,993 |
3,123,450 |
+9.8% |
Morgan Stanley |
31 May 2026 |
| BWG |
BrandywineGLOBAL-Global Income Opportunities Fund Inc |
Common Stock |
10% |
$15,049,966 |
-$1,590,758 |
1,733,867 |
-9.6% |
Morgan Stanley |
30 Sep 2025 |
| OPEN |
Opendoor Technologies Inc. |
Common Stock |
10% |
$458,034,591 |
+$221,436,479 |
97,870,639 |
+94% |
Morgan Stanley |
31 Mar 2026 |
| ODD |
Oddity Tech Ltd |
Class A Ordinary Shares |
10% |
$142,277,540 |
+$26,390,194 |
4,692,531 |
+23% |
Morgan Stanley |
28 Feb 2026 |
| XFOR |
X4 Pharmaceuticals, Inc |
Common Stock |
10% |
$29,940,219 |
+$2,318,051 |
8,884,338 |
+8.4% |
Morgan Stanley |
28 Feb 2026 |
| BLKB |
BLACKBAUD INC |
Common Stock |
10% |
$150,051,656 |
+$3,476,042 |
4,619,817 |
+2.4% |
Morgan Stanley |
31 May 2026 |
| BGY |
BlackRock Enhanced International Dividend Trust |
Common Stock |
10% |
$51,709,215 |
+$1,180,885 |
9,119,791 |
+2.3% |
Morgan Stanley |
30 Apr 2026 |
| AUR |
Aurora Innovation, Inc. |
Class A Common Stock |
10% |
$1,390,387,488 |
+$185,437,451 |
165,522,320 |
+15% |
Morgan Stanley |
31 May 2026 |
| WOLF |
WOLFSPEED, INC. |
Common Stock |
9.5% |
$47,914,160 |
|
2,455,877 |
|
Morgan Stanley |
31 Dec 2025 |
| CHW |
Calamos Global Dynamic Income Fund |
Common Shares |
9.3% |
$46,164,980 |
|
5,933,802 |
|
Morgan Stanley |
31 Mar 2026 |
| CCCC |
C4 Therapeutics, Inc. |
Common Stock |
9.3% |
$17,140,705 |
+$8,067,473 |
8,974,191 |
+89% |
Morgan Stanley |
31 Dec 2025 |
| RPRX |
Royalty Pharma plc |
Class A Ordinary Shares |
9.2% |
$1,394,427,274 |
|
38,907,011 |
|
Morgan Stanley |
30 Jun 2025 |
| FTHY |
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND |
Common Shares |
8.9% |
$44,513,862 |
+$6,830,851 |
3,290,012 |
+18% |
Morgan Stanley |
31 Mar 2026 |
| OPP |
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. |
Common Stock |
8.7% |
$16,351,256 |
|
1,998,931 |
|
Morgan Stanley |
31 Dec 2024 |
| QXO |
QXO, Inc. |
Common Stock |
8.6% |
$1,349,039,607 |
+$377,000,863 |
57,700,582 |
+39% |
Morgan Stanley |
31 Dec 2025 |
| GDV |
GABELLI DIVIDEND & INCOME TRUST |
Common Stock |
8.6% |
$217,846,715 |
|
7,617,018 |
|
Morgan Stanley |
31 Dec 2025 |
| BBNX |
Beta Bionics, Inc. |
Common Stock |
8.6% |
$74,305,196 |
+$16,109,185 |
3,739,567 |
+28% |
Morgan Stanley |
30 Sep 2025 |
| KRNT |
Kornit Digital Ltd. |
Ordinary Shares |
8.6% |
$59,821,087 |
+$17,372,814 |
3,945,982 |
+41% |
Morgan Stanley |
31 Dec 2025 |
| CRTO |
Criteo S.A. |
American Depository Shares / Ordinary Shares |
8.5% |
$92,219,507 |
+$23,453,788 |
4,474,503 |
+34% |
Morgan Stanley |
31 Dec 2025 |
| WIW |
WESTERN ASSET INFLATION-LINKED OPPORTUNITIES & INCOME FUND |
Common Shares of Beneficial Interest |
8.5% |
$45,921,799 |
+$6,006,198 |
5,224,323 |
+15% |
Morgan Stanley |
30 Jun 2025 |
| FFA |
FIRST TRUST ENHANCED EQUITY INCOME FUND |
Common Stock |
8.5% |
$34,843,914 |
|
1,701,363 |
|
Morgan Stanley |
30 Jun 2025 |
| LUNG |
Pulmonx Corp |
Common Stock |
8.5% |
$17,530,110 |
+$2,200,052 |
3,390,737 |
+14% |
Morgan Stanley |
31 Mar 2025 |
| GUG |
Guggenheim Active Allocation Fund |
Common Shares |
8.4% |
$43,332,058 |
+$5,735,855 |
2,777,696 |
+15% |
Morgan Stanley |
30 Sep 2025 |
| NXDTPRA |
NEXPOINT DIVERSIFIED REAL ESTATE TRUST |
5.50% Series A Cumulative Preferred Shares |
8.4% |
$4,022,523 |
+$1,111,197 |
283,876 |
+38% |
Morgan Stanley |
30 Sep 2025 |
| NPCE |
NeuroPace Inc |
Common Stock |
8.3% |
$28,926,723 |
|
2,489,391 |
|
Morgan Stanley |
31 Dec 2024 |
| DLB |
Dolby Laboratories, Inc. |
Class A Common Stock |
8.2% |
$309,079,032 |
-$72,115,324 |
5,020,777 |
-19% |
Morgan Stanley |
31 Mar 2026 |
| AOD |
abrdn Total Dynamic Dividend Fund |
Common Stock |
8.2% |
$81,320,421 |
-$13,674,089 |
8,596,239 |
-14% |
Morgan Stanley |
31 Mar 2026 |
| RIV |
RIVERNORTH OPPORTUNITIES FUND, INC. |
Common Stock |
8.2% |
$20,391,036 |
|
1,768,520 |
|
Morgan Stanley |
31 Mar 2025 |
| EVH |
Evolent Health, Inc. |
Class A Common Stock |
8.1% |
$37,755,903 |
+$3,682,702 |
9,097,808 |
+11% |
Morgan Stanley |
31 Dec 2025 |
| NPCT |
NUVEEN CORE PLUS IMPACT FUND |
Common Shares of Beneficial Interest |
8% |
$23,432,541 |
-$3,056,028 |
2,290,571 |
-12% |
Morgan Stanley |
31 Dec 2025 |
| INBX |
Inhibrx Biosciences, Inc. |
Common Stock |
7.9% |
$84,668,884 |
|
1,155,416 |
|
Morgan Stanley |
31 Dec 2025 |
| SPXX |
Nuveen S&P 500 Dynamic Overwrite Fund |
Common Shares |
7.8% |
$185,377,726 |
|
10,765,257 |
|
Morgan Stanley |
31 Mar 2026 |
| AMWL |
American Well Corp |
Class A Common Stock |
7.8% |
|
|
1,156,087 |
|
Morgan Stanley |
31 Mar 2026 |
| NFJ |
Virtus Dividend, Interest & Premium Strategy Fund |
Common Shares of Beneficial Interest |
7.7% |
$84,319,912 |
|
7,325,796 |
|
Morgan Stanley |
31 Mar 2025 |
| CHH |
CHOICE HOTELS INTERNATIONAL INC /DE |
Common Stock |
7.6% |
$382,917,482 |
|
3,532,775 |
|
Morgan Stanley |
31 Dec 2025 |
| ZEPP |
Zepp Health Corp |
Class A Ordinary Shares / American Depositary Receipts |
7.5% |
$141,570,863 |
|
8,472,224 |
|
Morgan Stanley |
30 Sep 2025 |
| FTF |
FRANKLIN LTD DURATION INCOME TRUST |
Common Shares of Beneficial Interest |
7.5% |
$18,033,794 |
+$2,792,276 |
3,020,736 |
+18% |
Morgan Stanley |
31 Mar 2026 |
| BRCB |
Black Rock Coffee Bar, Inc. |
Class A Common Stock |
7.4% |
$28,479,074 |
+$8,220,545 |
1,292,154 |
+41% |
Morgan Stanley |
31 Dec 2025 |
| BEBE |
TGE Value Creative Solutions Corp |
Class A Ordinary Shares |
7.3% |
$10,769,170 |
|
1,089,997 |
|
Morgan Stanley |
31 Mar 2026 |
| RDWR |
RADWARE LTD |
Ordinary Shares |
7.2% |
$85,095,001 |
+$12,146,089 |
3,052,188 |
+17% |
Morgan Stanley |
31 Mar 2026 |
| EMO |
ClearBridge Energy Midstream Opportunity Fund Inc. |
Common Stock |
7.2% |
$58,199,824 |
-$10,051,350 |
1,309,627 |
-15% |
Morgan Stanley |
31 Dec 2025 |
| AFRM |
Affirm Holdings, Inc. |
Class A Common Stock |
7.1% |
$1,077,709,997 |
-$71,634,928 |
20,737,156 |
-6.2% |
Morgan Stanley |
31 Mar 2026 |
| CACI |
CACI INTERNATIONAL INC /DE/ |
Common Stock |
7.1% |
$773,618,753 |
-$131,774,185 |
1,551,022 |
-15% |
Morgan Stanley |
30 Sep 2025 |
| NHC |
NATIONAL HEALTHCARE CORP |
Common Stock |
7.1% |
$185,590,053 |
|
1,102,537 |
|
Morgan Stanley |
31 Dec 2025 |
| XIFR |
XPLR Infrastructure, LP |
Common Units |
7.1% |
$70,780,155 |
|
6,664,798 |
|
Morgan Stanley |
31 Mar 2026 |
| GROV |
Grove Collaborative Holdings, Inc. |
Class A Common Stock |
7.1% |
$3,624,801 |
-$572,179 |
2,946,993 |
-14% |
Morgan Stanley |
31 Dec 2025 |
| AMG |
AFFILIATED MANAGERS GROUP, INC. |
Common Stock |
7% |
$472,898,962 |
|
1,983,387 |
|
Morgan Stanley |
30 Sep 2025 |
| SPHR |
Sphere Entertainment Co. |
Class A Common Stock |
7% |
$255,870,716 |
+$33,498,553 |
2,011,246 |
+15% |
Morgan Stanley |
31 Mar 2026 |
| ROIV |
Roivant Sciences Ltd. |
Common Shares |
6.9% |
$1,401,593,746 |
-$170,482,433 |
49,473,835 |
-11% |
Morgan Stanley |
31 Mar 2026 |
| DIN |
Dine Brands Global, Inc. |
Common Stock |
6.9% |
$23,352,892 |
+$3,207,525 |
889,973 |
+16% |
Morgan Stanley |
31 Mar 2026 |
| GAXY |
GALAXY NEXT GENERATION, INC. |
Common Stock |
6.9% |
$48,360 |
|
4,836,001 |
|
Morgan Stanley |
31 Dec 2024 |
| TSHA |
Taysha Gene Therapies, Inc. |
Common Stock |
6.7% |
$44,506,820 |
-$2,034,437 |
16,858,644 |
-4.4% |
Morgan Stanley |
30 Jun 2025 |
| CEVA |
CEVA INC |
Common Stock |
6.7% |
$36,843,172 |
|
1,609,575 |
|
Morgan Stanley |
30 Jun 2025 |
| NBB |
Nuveen Taxable Municipal Income Fund |
Common Shares of Beneficial Interest |
6.6% |
$30,508,656 |
|
1,944,465 |
|
Morgan Stanley |
30 Jun 2025 |
| LSAK |
LESAKA TECHNOLOGIES INC |
Common Stock |
6.6% |
$24,862,671 |
|
5,212,300 |
|
Morgan Stanley |
31 Dec 2024 |
| ONON |
On Holding AG |
Class A Ordinary Shares |
6.5% |
$905,813,989 |
|
19,166,610 |
|
Morgan Stanley |
31 Dec 2025 |
| ACP |
abrdn Income Credit Strategies Fund |
Common Shares |
6.5% |
$43,501,683 |
+$12,288,099 |
8,177,008 |
+39% |
Morgan Stanley |
31 Mar 2026 |
| EMD |
WESTERN ASSET EMERGING MARKETS DEBT FUND INC. |
Common Stock |
6.5% |
$37,287,679 |
-$18,083,137 |
3,797,116 |
-33% |
Morgan Stanley |
31 Mar 2026 |
| STOK |
Stoke Therapeutics, Inc. |
Common Stock |
6.5% |
$32,588,288 |
|
3,426,739 |
|
Morgan Stanley |
31 Dec 2024 |
| NPFD |
Nuveen Variable Rate Preferred & Income Fund |
Common Shares of Beneficial Interest |
6.5% |
$30,415,184 |
+$18,885,182 |
1,567,793 |
+164% |
Morgan Stanley |
30 Jun 2025 |
| RGT |
ROYCE GLOBAL TRUST, INC. |
Common Stock |
6.5% |
$5,253,799 |
|
424,721 |
|
Morgan Stanley |
30 Jun 2025 |
| EVGO |
EVgo Inc. |
Class A Common Stock |
6.4% |
$17,614,403 |
|
9,079,589 |
|
Morgan Stanley |
31 Mar 2026 |
| PCOR |
PROCORE TECHNOLOGIES, INC. |
Common Stock |
6.3% |
$692,335,002 |
|
9,494,446 |
|
Morgan Stanley |
30 Sep 2025 |
| PSF |
Cohen & Steers Select Preferred & Income Fund, Inc. |
Common Stock |
6.3% |
$14,718,575 |
|
761,831 |
|
Morgan Stanley |
31 Mar 2025 |
| HIO |
WESTERN ASSET HIGH INCOME OPPORTUNITY FUND INC. |
Common Stock |
6.2% |
$21,539,379 |
+$1,362,347 |
5,853,092 |
+6.8% |
Morgan Stanley |
31 Mar 2026 |
| FTW |
PRESIDIO PRODUCTION COMPANY |
Class A common stock, $0.0001 par value per share |
6.2% |
$18,977,171 |
|
1,717,391 |
|
MORGAN STANLEY |
31 Mar 2026 |
| ATR |
APTARGROUP, INC. |
Common Stock |
6.1% |
$484,617,925 |
|
4,019,724 |
|
Morgan Stanley |
31 Dec 2025 |
| JBGS |
JBG SMITH Properties |
Common Shares |
6.1% |
$54,154,886 |
+$9,581,664 |
3,624,825 |
+21% |
Morgan Stanley |
31 Mar 2026 |
| TYG |
TORTOISE ENERGY INFRASTRUCTURE CORP |
Common Stock |
6.1% |
$45,402,272 |
+$3,664,425 |
1,045,172 |
+8.8% |
Morgan Stanley |
30 Jun 2025 |
| BOE |
BlackRock Enhanced Global Dividend Trust |
Common Shares of Beneficial Interest |
6.1% |
$38,762,843 |
+$5,630,000 |
3,382,447 |
+17% |
Morgan Stanley |
31 Mar 2026 |
| NML |
Neuberger Berman Energy Infrastructure & Income Fund Inc. |
Common Stock |
6.1% |
$30,534,158 |
|
3,458,002 |
|
Morgan Stanley |
30 Jun 2025 |
| IHD |
Voya Emerging Markets High Dividend Equity Fund |
Common Shares of Beneficial Interest |
6.1% |
$6,813,910 |
|
1,086,748 |
|
Morgan Stanley |
31 Dec 2025 |
| RA |
Brookfield Real Assets Income Fund Inc. |
Common Shares |
6% |
$42,672,631 |
+$11,100,379 |
3,318,245 |
+35% |
Morgan Stanley |
31 Mar 2026 |
| RMT |
ROYCE MICRO-CAP TRUST, INC. |
Common Stock |
6% |
$25,326,764 |
|
3,092,401 |
|
Morgan Stanley |
31 Mar 2025 |
| AIJTY |
Jianpu Technology Inc. |
Class A Ordinary Shares / American Depositary Shares |
6% |
$20,219,108 |
|
22,218,800 |
|
Morgan Stanley |
31 Dec 2025 |
| PROK |
PROKIDNEY CORP. |
Class A Common Stock |
6% |
$19,510,759 |
|
8,519,982 |
|
Morgan Stanley |
31 Dec 2025 |
| USPH |
U S PHYSICAL THERAPY INC /NV |
Common Stock |
5.9% |
$60,006,488 |
|
889,644 |
|
Morgan Stanley |
31 Dec 2024 |
| TBCH |
Turtle Beach Corp |
Common Stock |
5.9% |
$11,977,445 |
|
1,156,124 |
|
Morgan Stanley |
31 Mar 2026 |
| OPPPRA |
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. |
4.375% Series A Cumulative Perpetual Preferred Stock |
5.9% |
$2,434,325 |
-$487,087 |
142,275 |
-17% |
Morgan Stanley |
30 Sep 2025 |
| TULP |
BLOOMIA HOLDINGS, INC. |
Common Stock |
5.9% |
$1,143,479 |
+$173,117 |
280,953 |
+18% |
Morgan Stanley |
30 Apr 2026 |
| WEX |
WEX Inc. |
Common Stock |
5.8% |
$334,404,445 |
-$67,129,368 |
2,015,213 |
-17% |
Morgan Stanley |
31 Mar 2026 |
| TCMD |
TACTILE SYSTEMS TECHNOLOGY INC |
Common Stock |
5.8% |
$37,505,381 |
|
1,293,289 |
|
Morgan Stanley |
31 Dec 2025 |
| SMLR |
Semler Scientific, Inc. |
Common Stock |
5.8% |
$35,996,155 |
|
790,603 |
|
Morgan Stanley |
30 Jun 2025 |
| ASGI |
abrdn Global Infrastructure Income Fund |
Common Shares of Beneficial Interest |
5.7% |
$30,484,187 |
+$6,233,014 |
1,640,699 |
+26% |
Morgan Stanley |
31 Mar 2025 |
| CAR |
AVIS BUDGET GROUP, INC. |
Common Stock |
5.6% |
$251,551,966 |
|
1,971,874 |
|
Morgan Stanley |
31 Dec 2025 |
| TBBB |
BBB FOODS INC |
Class A Common Shares |
5.6% |
$65,415,605 |
|
2,176,892 |
|
Morgan Stanley |
31 Dec 2024 |
| KIO |
KKR Income Opportunities Fund |
Common Shares |
5.6% |
$25,687,406 |
|
2,295,568 |
|
Morgan Stanley |
31 Mar 2026 |
| VCV |
Invesco California Value Municipal Income Trust |
Common Shares of Beneficial Interest |
5.5% |
$29,620,105 |
|
2,623,570 |
|
Morgan Stanley |
31 Dec 2025 |
| FUN |
Six Flags Entertainment Corporation/NEW |
Common Stock |
5.4% |
$96,937,931 |
-$64,778,292 |
5,514,103 |
-40% |
Morgan Stanley |
31 Mar 2026 |
| NBXG |
Neuberger Berman Next Generation Connectivity Fund Inc. |
Shares of Common Stock |
5.4% |
$51,115,724 |
|
4,245,492 |
|
Morgan Stanley |
31 Mar 2025 |